RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Return on equity (%)

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.3B
P/E ratio
22.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
May 31, 2025-5.1+7.81%
May 31, 2024-4.7-193.49%
May 31, 20235.1-27.88%
May 31, 20227+1.30%
May 31, 20216.9-30.81%
May 31, 202010+2346.34%
May 31, 20190.4-183.67%
May 31, 2018-0.5-508.33%
May 31, 20170.1-98.11%
May 31, 20166.3+59.30%
May 31, 20154-45.63%
May 31, 20147.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)